Can you shut the F up or not and stop blabbing away saying will LU as the MM are monitoring all apps for people like you, this will make the change their strategy to goreng the counter in future. If know how to make money keep it to yourself !!!!
this to tell u people nowadays don't open your stupid mouths all here saying easy money all the time, the sharks will change their strategy when they see people like this fool here lalazai9 blabbing away I top up how much this and that , just keep to yourselves can already !!!!
sekchuan if you only lose when investing and never gain, why don't you stop investing completely? that way you will have more then losing from you investment. I don't think it is right to call it as investment if you only lose rather than gain.
TopGlove QR out! Profit 2.4b!!! Giving 16.5sen dividend, based on current RM6.99 price, it is 2% dividend, and which banks pays you 2% interest rate? HLT will be push up and limit today!
Maybe trap, maybe no...one thing is for sure...don’t invest unless you have a positive and strong mindset. All the doubts you cast only makes you more jittery...,in or don’t in ah? All in or don’t all in ah! How now? I scared? I not scared? My thoughts are I will hold for mid to long term, I have a TP in mind...my own...not based on what anyone else screams in this forum.
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
Not going good. Glove price has been unstable since the first vaccine news came out. Merely can look at TA chart and bet on a short rebound after that.
If you lucky you can earn 30% if you able to see the correct entry price which is very difficult. Based on the glove play pattern trending now is that will collect like few days before any good news announce on the glove. After that, they will dump to lock profit.
This kind of pattern has been repeated for 2 times I had see so far after the vaccine news came out.
Today Top Glove released its 1QFY2021 report. You can access the full report here.
The stock has been trading at below RM7 level for the better part of the last few weeks on a myriad of news perceived as bad. Albeit all that, the company posted a net profit of RM2.38 billion for the quarter. They have approximately 8.2 billion outstanding shares. This gives the company an EPS of RM0.29 for the quarter. Let's do a bit of calculating:
- Assume the profits don't increase (they are expected to, but we will be conservative).
- This would mean an EPS of RM1.16 for FY2021.
- This translates into a forward P/E of 6 at price RM7 (as of writing this, the price is RM6.84)
This make is one of the lowest valued stocks in the entire stock market, with only 5 companies having forward P/Es of below 6 at the time of writing this.
If we assume that a stock is fairly priced at P/E 15, this would mean that the fair value of Top Glove is RM17.40.
At the same time, one of Top Glove's main competitors in the glove manufacturing market - Hartalega, has a consensus forward P/E of about 19.5 based on its current market price.
Let's assume that the market assigns the same valuation to Top Glove as it does to its direct competitor and simiarly-sized peer Hartalega. In this case, Top Glove's market price would be RM22.62.
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Stockhunter88
2,031 posts
Posted by Stockhunter88 > 2020-12-09 08:56 | Report Abuse
https://www.google.com/amp/s/thenewdaily.com.au/news/coronavirus/2020/12/09/pfizer-oxford-astrazeneca-vaccines/amp/